2. Sensitivity analyses for depression symptoms at end of treatment in psychological versus control trials.
| Comparison | Sensitivity analysis | Study references [n] | SMD | I2 |
| Psychological vs control | None (Analysis 1.1) | Barth 2005; Dao 2011; Fang 2003; Freedland 2009; McLaughlin 2005; MoodCare 2011; SPIRR‐CAD 2011; U‐CARE 2018; WIDeCAD 2017; Zarea 2014 (n = 1226) | −0.55 (95% CI −0.92 to −0.19) | 88 |
| Psychological vs control | Constrained to trials without depression disorders as part of the inclusion criteria | Barth 2005; Dao 2011; Fang 2003; McLaughlin 2005; MoodCare 2011; SPIRR‐CAD 2011; U‐CARE 2018; WIDeCAD 2017; Zarea 2014 (n = 1145) | −0.53 (95% CI −0.92 to −0.13) | 89 |
| Psychological vs control | Constrained to depression (e.g. excluding trials with mixed depression and/or anxiety as part of the inclusion criteria) | Barth 2005; Freedland 2009; MoodCare 2011; SPIRR‐CAD 2011; WIDeCAD 2017 (n = 681) | −0.27 (95% CI −0.58 to 0.03) | 65 |
| Psychological vs control | Constrained to cognitive‐behavioural therapy trials | Dao 2011; Freedland 2009; MoodCare 2011; U‐CARE 2018; WIDeCAD 2017 (n = 571) | −0.48 (95% CI −0.77 to −0.19) | 61 |
CI = confidence interval; SMD = standardised mean difference